These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 23599406

  • 1. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.
    Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S, Gesualdo L.
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1115-25. PubMed ID: 23599406
    [Abstract] [Full Text] [Related]

  • 2. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 3. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J.
    J Biomed Nanotechnol; 2012 Feb; 8(1):133-9. PubMed ID: 22515101
    [Abstract] [Full Text] [Related]

  • 4. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.
    Graterol F, Navarro-Muñoz M, Ibernon M, López D, Troya MI, Pérez V, Bonet J, Romero R.
    BMC Nephrol; 2013 Apr 11; 14():82. PubMed ID: 23577616
    [Abstract] [Full Text] [Related]

  • 5. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.
    Shen P, Shen J, Li W, He L.
    Clin Lab; 2014 Apr 11; 60(10):1709-15. PubMed ID: 25651718
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic urinary proteome profile for immunoglobulin a nephropathy.
    Samavat S, Kalantari S, Nafar M, Rutishauser D, Rezaei-Tavirani M, Parvin M, Zubarev RA.
    Iran J Kidney Dis; 2015 May 11; 9(3):239-48. PubMed ID: 25957429
    [Abstract] [Full Text] [Related]

  • 7. Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
    Neprasova M, Maixnerova D, Novak J, Reily C, Julian BA, Boron J, Novotny P, Suchanek M, Tesar V, Kacer P.
    Dis Markers; 2016 May 11; 2016():3650909. PubMed ID: 27799660
    [Abstract] [Full Text] [Related]

  • 8. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 May 11; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 9. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, Zubarev RA.
    PLoS One; 2013 May 11; 8(12):e80830. PubMed ID: 24339887
    [Abstract] [Full Text] [Related]

  • 10. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y.
    Clin J Am Soc Nephrol; 2012 Sep 11; 7(9):1385-93. PubMed ID: 22700887
    [Abstract] [Full Text] [Related]

  • 11. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?
    Marek-Bukowiec K, Konieczny A, Ratajczyk K, Witkiewicz W.
    Dis Markers; 2018 Sep 11; 2018():5205831. PubMed ID: 29606986
    [Abstract] [Full Text] [Related]

  • 12. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 11; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 13. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec 11; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 14. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.
    Julian BA, Wittke S, Haubitz M, Zürbig P, Schiffer E, McGuire BM, Wyatt RJ, Novak J.
    World J Urol; 2007 Oct 11; 25(5):467-76. PubMed ID: 17619884
    [Abstract] [Full Text] [Related]

  • 15. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
    Mucha K, Bakun M, Jaźwiec R, Dadlez M, Florczak M, Bajor M, Gala K, Pączek L.
    Pol Arch Med Wewn; 2014 Oct 11; 124(7-8):380-6. PubMed ID: 24938435
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V, Lochman P, Pika T, Zapletalová J, Minařík J, Bačovský J.
    Cas Lek Cesk; 2015 Oct 11; 154(6):292-302. PubMed ID: 26750626
    [Abstract] [Full Text] [Related]

  • 17. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
    Hutchison CA, Harding S, Hewins P, Mead GP, Townsend J, Bradwell AR, Cockwell P.
    Clin J Am Soc Nephrol; 2008 Nov 11; 3(6):1684-90. PubMed ID: 18945993
    [Abstract] [Full Text] [Related]

  • 18. Markers for the progression of IgA nephropathy.
    Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V.
    J Nephrol; 2016 Aug 11; 29(4):535-41. PubMed ID: 27142988
    [Abstract] [Full Text] [Related]

  • 19. Matrix-assisted laser desorption/ionization mass spectrometry imaging to uncover protein alterations associated with the progression of IgA nephropathy.
    Ivanova M, Dyadyk O, Ivanov D, Clerici F, Smith A, Magni F.
    Virchows Arch; 2020 Jun 11; 476(6):903-914. PubMed ID: 31838587
    [Abstract] [Full Text] [Related]

  • 20. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M.
    Nephrol Dial Transplant; 2011 Jan 11; 26(1):170-7. PubMed ID: 20615910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.